Clinical Trial Update: Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer [Phase 2]

View source ↗

Summary

An update on a Phase 2 clinical trial evaluating Biolosion in combination with standard neoadjuvant therapy for triple-negative breast cancer; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Biolosion

Snippet

Sponsor: Sun Yat-sen University | Conditions: Breast Cancer, Triple Negative Breast Cancer (TNBC) | Phase 2 | Status: RECRUITING